Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

The safety of radiofrequency thermal ablation in the treatment of liver malignancies.

Casaril A, Abu Hilal M, Harb A, Campagnaro T, Mansueto G, Nicoli N.

Eur J Surg Oncol. 2008 Jun;34(6):668-72. Epub 2007 Jul 27.

PMID:
17681717
2.

The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.

Choy PY, Koea J, McCall J, Holden A, Osbourne M.

N Z Med J. 2002 Aug 9;115(1159):U128.

PMID:
12362172
3.

Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches.

Machi J, Uchida S, Sumida K, Limm WM, Hundahl SA, Oishi AJ, Furumoto NL, Oishi RH.

J Gastrointest Surg. 2001 Sep-Oct;5(5):477-89.

PMID:
11985998
4.

Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ.

Ann Surg Oncol. 2000 Sep;7(8):593-600.

PMID:
11005558
5.

Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.

Tepel J, Hinz S, Klomp HJ, Kapischke M, Kremer B.

Eur J Surg Oncol. 2004 Jun;30(5):551-5.

PMID:
15135485
6.

Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?

Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.

Eur J Gastroenterol Hepatol. 2008 Mar;20(3):196-201. doi: 10.1097/MEG.0b013e3282f1cc4a.

PMID:
18301300
7.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
8.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276
9.

[Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications].

Chen MH, Yan K, Yang W, Gao W, Dai Y, Wang YB, Zhang H, Huo L, Xing BC, Huang XF.

Beijing Da Xue Xue Bao. 2005 Jun 18;37(3):292-6. Chinese.

10.

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, Granchi J, Curley SA.

Am J Surg. 1999 Dec;178(6):592-9.

PMID:
10670879
11.

Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.

Chen TM, Huang PT, Lin LF, Tung JN.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e445-50. Epub 2007 Aug 7.

PMID:
17683478
12.
13.

Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases.

Berber E, Siperstein AE.

Surg Endosc. 2007 Apr;21(4):613-8. Epub 2007 Feb 8.

PMID:
17287917
14.

Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.

Wang YH, Liu JF, Li F, Li A, Liu Q, Liu DB, Liu DG, Wang YJ.

Chin Med J (Engl). 2009 Apr 20;122(8):889-94.

PMID:
19493409
15.

Long-term survival after radiofrequency ablation of complex unresectable liver tumors.

Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, Bilchik AJ.

Arch Surg. 2006 Jun;141(6):581-7; discussion 587-8.

PMID:
16785359
16.

Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.

Ishiko T, Beppu T, Sugiyama S, Masuda T, Takahashi M, Komori H, Takamori H, Hirota M, Kanemitu K, Baba H.

Surg Laparosc Endosc Percutan Tech. 2008 Jun;18(3):272-6. doi: 10.1097/SLE.0b013e31816a24bf.

PMID:
18574414
17.

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.

Jpn J Clin Oncol. 2007 Sep;37(9):658-72. Epub 2007 Aug 31.

PMID:
17766723
18.

Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver.

Poggi G, Riccardi A, Quaretti P, Teragni C, Delmonte A, Amatu A, Saini G, Mazzucco M, Bernardo A, Palumbo R, Canto A, Bernieri S, Bernardo G.

Anticancer Res. 2007 Jul-Aug;27(4C):2911-6.

19.

Radiofrequency ablation for unresectable tumors of the liver.

Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.

Am Surg. 2008 Jul;74(7):594-600; discussion 600-1.

PMID:
18646476
20.

Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study.

Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.

Hepatogastroenterology. 2007 Jun;54(76):985-9.

PMID:
17629022

Supplemental Content

Support Center